Rethinking the Customer Engagement Model in Japan for COVID-19 and Beyond L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma Unlike many other markets in the world, Japan had until very recently been driven by ‘share-of-voice’, with market development and patient share being largely sensitive to sales activity. 01022024160132
Published Articles Life Sciences & Pharma Biopharma predictions for 2026: thoughts from LEK Consulting’s Simon Middleton January 14, 2026
Smart Chart Life Sciences & Pharma Innovation in Animal Health: Turning Potential into Progress October 14, 2025
Executive Insights Life Sciences & Pharma Behavior-First Biopharma Go-to-Market Strategies October 6, 2025
Video / Webinar Healthcare Services Australia's Clinical Trials: Innovation and Growth February 24, 2025
Case Study Private Equity Future Ready: Comprehensive Operational Due Diligence on a Medtech and Life Sciences… February 24, 2025 A private equity firm approached L.E.K. Consulting to conduct operational due diligence on a promising precision medtech and life sciences engineering…
